<DOC>
	<DOCNO>NCT02839668</DOCNO>
	<brief_summary>Because neoplastic disease one leading cause death worldwide breast cancer one frequent neoplasia among woman , possibility influence evolution patient start moment surgical intervention use perianesthesic intervention scientific topic high interest . The study compare two anesthetic technique efficiency lower factor favorize dissemination neoplasia role prevention postoperative pain . The serum level vascular endothelial growth factor A ( VEGF-A ) determine surgical intervention use two different type anesthesia ( inhalational intravenous ) , immunohistochemical expression vascular endothelial growth factor receptor ( VEGFR ) determine excised tissue . For two different type anesthesia continuous infusion lidocaine 1 % associate . The study compare short-term long term-outcome patient assign two different type anesthesia immediate postoperative evolution .</brief_summary>
	<brief_title>The Impact Intravenous Anaesthesia Angiogenesis Patients With Breast Cancer ( TIVA/TCI-BC )</brief_title>
	<detailed_description>The study enroll patient age 18 80 year old , diagnose breast cancer without proof disease dissemination medical imaging . After obtain informed consent patient computer randomize 4 group . Each group benefit certain type anesthesia . The first group assign general anesthesia use Sevoflurane maintenance hypnosis , second group assign general anesthesia Sevoflurane continuous infusion lidocaine 1 % . The thrid group assign total intravenous anesthesia use propofol maintenance hypnosis fourth group assign total intravenous anesthesia propofol continuous infusion lidocaine 1 % . Before surgical procedure blood sample drawn patient measurement serum vascular endothelial growth factor A ( VEGF-A ) . All patient receive pre-medication night intervention low molecular weight heparin ( LMWH ) midazolam 5mg morning intervention . For first two group anesthetic induction conduct use propofol 1,5-2 mg/kg , fentanyl 1-3 microg/kg , atracurium 0,5 mg/kg.For maintenance anesthesia Sevoflurane use alveolar concentration 1-1,5 MAC . Intraoperative anesthesia ensure use fentanyl bolus 0.5-2.5 microg/kg muscular relaxation need mechanical ventilation maintain use bolus 10 mg atracurium . At end surgery neuromuscular blockade antagonize neostigmine 0.05 mg/kg atropine 0.2 mg/kg . For second group induction anesthesia patient administer bolus lidocaine 1 % 1.5 mg/kg continuous infusion lidocaine 1 % 1 mg/kg/h associate throughout procedure 24 h postoperative . The postoperative analgesia assure administer acetaminophen 1 g 8 h tramadol 25-50 mg 4-6 h need . For third fourth group induction aneshesia make use propofol administer target control infusion ( TCI ) technique target plasma concentration 4 microg/ml . Throughout intervention plasma concentration propofol adjust increment 0.2 microg/ml maintain BIS 45-60 . To attenuate response laryngoscopy patient receive bolus fentanyl 1-3 microg/ml . During intervention fentanyl administer boluses 0.5-2.5 microg/kg need . Muscular relaxation necessary intubation provide use atracurium 0.5 mg/kg induction anesthesia 10 mg bolus surgery need . At end surgery neuromuscular blockade antagonize neostigmine 0.05 mg/kg atropine 0.2 mg/kg . For fourth group induction anesthesia patient administer bolus lidocaine 1 % 1.5 mg/kg continuous infusion lidocaine 1 % 1 mg/kg/h associate throughout procedure 24 h postoperative.Postoperative analgesia assure administer acetaminophen 1 g 8 h tramadol 25-50 mg 4-6 h need . Throughout surgical intervention patient monitor accordingly American Society Anesthesiologists ( ASA ) standard ( electrocardiogram-ECG , heart rate- HR , peripheral capillary oxygen saturation- SpO2 , non-invasive blood pressure- NIBP , capnography 3rd 4th group bispectral index - BIS monitor ) . In postoperative period non-invasive blood pressure -NIBP , heart rate- HR , peripheral capillary oxygen saturation SpO2 , intensity pain 24 48 h monitored.Vascular endothelial growth factor- VEGF level monitor 24 h postoperative use ELISA technique . Vascular endothelial growth factor receptor 1 2 ( VEGFR1 VEGFR2 ) determine use immunohistochemical staining .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Sevoflurane</mesh_term>
	<mesh_term>Atropine</mesh_term>
	<mesh_term>Tramadol</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<mesh_term>Neostigmine</mesh_term>
	<criteria>diagnosis breast cancer ASA risk class IIII metastatic disease hepatic , pulmonary metastasis type I II diabetes rheumatoid arthritis osteoarthritis ischemic cardiovascular disease ( history myocardial infarction , angina ) peripheral vascular disease endometriosis allergy lidocaine , fentanyl , propofol , sevoflurane , atracurium , midazolam , acetaminophen , tramadol neuropsychiatric disorder incapacity understand study refusal participation</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>breast cancer</keyword>
	<keyword>angiogenesis</keyword>
	<keyword>VEGF</keyword>
</DOC>